Funding
Andrew Forrest backs Sydney biotech startup in $26 million raise
Sydney biotech company SpeeDx has raised $26 million for US expansion and to ramp up its diagnostic technologies for illness such such as cancer. The raise included $5 million from Dr Andrew Forrest’s new $250 million VC fund Tenmile, which the WA mining billionaire launched last year with backing from his private investment company, Tattarang. Existing… Read more »
